Current Issue

Selected topics in moving from Gel Clot to Kinetic BET Testing

Kevin Williams, Research Scientist Hospira Inc

Implementation of Single-Use Bioreactors for Viral Vaccines Process Development

Ludovic Peeters, Scientist – New Technologies GSK

Increasing Flexibility in Vaccine Manufacturing Processes and Facilities with Single-Use D...

Tony D’Amore, Vice President, Bioprocess R&D Yan-ping Yang, Director of Downstream...

The Coming of Age of Heart in a Dish

Ashish Mehta, Senior Research Scientist; Chrishan Ramachandra, Research Fellow; Winsto...

How to Leverage Technologies for the Discovery of New Vaccines

Andrew Natenshon, Head China Research Strategy and Operations Novartis Vaccines & Dia...

Evolution of Culture Systems for Viral Vector Production: Advantages, Challenges and Cost ...

PODCAST INTERVIEW Emmanuelle Cameau Senior Bioreactor Applications Scientist within the Sc...


Featured Articles

Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules

Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification

John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey DoyleManager, PAT Projects in the Process Analytical Sciences Group
Paul JeffersManager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’NeillAnalytical Chemist
Pfizer

Navigating Technology Transfer

View All Featured Articles

Headline News

Collaboration Announced by Moderna and ROVI for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate


Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19


Priority Review Granted by FDA to Merck’s Supplemental Biologics License Application for KEYTRUDA® for Second-Line Treatment of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma


Read All Headlines

Upcoming Webinars

mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO at Genor Biopharma, Walvax Bio Group and Sarah (Xuyu) Wang, Head of Segment Marketing, Biosimilars and Bioconjugations at Sartorius Stedim Biotech
09th October 2020


Improving Efficiency in Upstream Process Development

Presented by Jackie Gonzalez, Senior Upstream Development Engineer at Takeda
24th November 2020


Fully Utilizing Closed Systems in Modern BioPharma Facilities

Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department and Ross W. Acucena, Applications Director, Entegris LifeScience
03rd September 2020


View All Upcoming Webinars

Past Webinars

Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented Yuyi Shen, Associate Director and Head of Development & Manufacturing at Bolt Biotherapeutics and John Cyganowski, Director of Manufacturing Sciences and Technologies Downstream Americas for MilliporeSigma
19th November 2018


Implementing CMC Strategies for scale-up operations in biologics manufacturing

Presented by Dr Anita Krishnan, Assistant Director, Head, CMC development at Lupin and Dr. Annu Uppal Manager Biopharmaceutical Applications at AB SCIEX
05th October 2018


Key components of a comprehensive program for the management of single use technologies in biologics manufacturing

Presented by John Maguire, Shire and Donald Young, ThermoFisher Scientific
18th July 2018


View All Past Webinars

Featured Companies

 

View All Companies

Featured Video

Successful Bioprocessing Project in 6 Steps

Discover how Pall’s integrated manufacturing solutions can help you accelerate the design and delivery of your next process; and how our teams combine best engineering and project management practices with an in-depth industry knowledge, and diverse equipment portfolio to deliver these benefits on time and on budget, ready for when you need them.

Read additional articles about how to bring your biologic to market as quickly as possible…

 

View All Videos

Technical Papers

Amsphere TM A3


Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins


Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH


Read All Technical Papers

Featured Products

Decrease Cleaning Validation Time and Resources


AdvantaPure


Amsphere™ A3 Protein A Resin – JSR Life Sciences


View All Products

© 2020 biopharma-asia.com. All rights reserved. Privacy Policy